ACS Medicinal Chemistry Letters · 2013 · 30 citations · 22 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructural BiologyLigand BindingProtein-ligand BindingHydrophobic InteractionsKinase InhibitorsLigand Binding AffinityPharmaceutical CocrystallizationPositionResidue-directed Inhibitor DesignSynthetic Analogues
To investigate the role played by the unique pre-DFG residue Val 195 of Cdc7 kinase on the potency of azaindole-chloropyridines (1), a series of novel analogues with various chloro replacements were synthesized and evaluated for their inhibitory activity against Cdc7. X-ray cocrystallization using a surrogate protein, GSK3β, and modeling studies confirmed the azaindole motif as the hinge binder. Weaker hydrophobic interactions with Met 134 and Val 195 by certain chloro replacements (e.g., H, methyl) led to reduced Cdc7 inhibition. Meanwhile, data from other replacements (e.g., F, O) indicated that loss of such hydrophobic interaction could be compensated by enhanced hydrogen bonding to Lys 90. Our findings not only provide an in-depth understanding of the pre-DFG residue as another viable position impacting kinase inhibition, they also expand the existing knowledge of ligand-Cdc7 binding.
22
Mammalian Cdc7–Dbf4 protein kinase complex is essential for initiation of DNA replication
Wei Jiang, D McDonald, Thomas J. Hope et al. · The EMBO Journal · 1999 · 222 citations · Full text